ROTUOC
Regents of the University of California Portfolio holdings
AUM
$515M
This Quarter Return
+17.63%
1 Year Return
+25.31%
3 Year Return
+76.79%
5 Year Return
+62.93%
10 Year Return
+567.68%
AUM
$713M
AUM Growth
+$713M
(+6.2%)
Cap. Flow
-$16.6M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
97.49%
Holding
35
New
5
Increased
3
Reduced
3
Closed
4
Top Buys
| 1 |
Blue Owl Capital
OBDC
|
$528M |
| 2 |
RAPT Therapeutics
RAPT
|
$45.6M |
| 3 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$5.11M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$1.82M |
| 5 |
The RealReal
REAL
|
$506K |
Top Sells
| 1 |
Allogene Therapeutics
ALLO
|
$45.9M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$7.81M |
| 3 |
Guardant Health
GH
|
$2.18M |
| 4 |
XYZ
Block, Inc.
XYZ
|
$936K |
Sector Composition
| 1 | Financials | 74.73% |
| 2 | Healthcare | 22.43% |
| 3 | Consumer Staples | 1% |
| 4 | Materials | 0.35% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Blue Owl Capital
OBDC
$7.33B
| $528M | 74.04% |
+42,783,344
| New | +$528M |
|
|
2
Allogene Therapeutics
ALLO
$251M
| $54.8M | 7.69% |
1,279,281
-1,071,649
| -46% | -$45.9M |
|
|
3
RAPT Therapeutics
RAPT
$188M
| $45.6M | 6.4% |
+1,572,237
| New | +$45.6M |
|
|
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $37.2M | 5.22% |
1,237,406
-260,000
| -17% | -$7.81M |
|
|
5
Guardant Health
GH
$8.41B
| $11M | 1.54% |
135,273
-26,889
| -17% | -$2.18M |
|
6
Estee Lauder
EL
$33B
| $6.3M | 0.88% |
33,400
| – | – |
|
|
ORTX
7
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.11M | 0.72% |
+851,201
| New | +$5.11M |
|
8
Air Products & Chemicals
APD
$65.5B
| $2.46M | 0.35% |
10,200
| – | – |
|
|
9
The RealReal
REAL
$879M
| $2.36M | 0.33% |
184,097
+39,583
| +27% | +$506K |
|
10
Intellia Therapeutics
NTLA
$1.22B
| $2.34M | 0.33% |
111,440
| – | – |
|
11
S&P Global
SPGI
$167B
| $1.98M | 0.28% |
6,000
| – | – |
|
|
12
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $1.82M | 0.26% |
+5,600
| New | +$1.82M |
|
13
Merck
MRK
$210B
| $1.67M | 0.23% |
21,600
| – | – |
|
14
Exxon Mobil
XOM
$487B
| $1.5M | 0.21% |
33,600
| – | – |
|
15
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.44M | 0.2% |
8,043
| – | – |
|
16
Verizon
VZ
$186B
| $978K | 0.14% |
17,735
| – | – |
|
17
Pfizer
PFE
$141B
| $904K | 0.13% |
27,645
| – | – |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $879K | 0.12% |
13,928
| – | – |
|
19
Texas Instruments
TXN
$184B
| $825K | 0.12% |
6,500
| – | – |
|
20
Coca-Cola
KO
$297B
| $804K | 0.11% |
18,000
| – | – |
|
21
Walt Disney
DIS
$213B
| $669K | 0.09% |
6,000
| – | – |
|
22
AT&T
T
$209B
| $656K | 0.09% |
21,688
| – | – |
|
23
Honeywell
HON
$139B
| $611K | 0.09% |
4,223
| – | – |
|
24
Marsh & McLennan
MMC
$101B
| $558K | 0.08% |
5,200
| – | – |
|
25
Zoom
ZM
$24.4B
| $545K | 0.08% |
2,149
+430
| +25% | +$109K |
|